The 50-year-old physician dropped into the leather chair in her psychiatrist’s Manhattan office. Her new normal, she announced to Dr. Deborah Cabaniss, was constant fatigue. Cabaniss noted that although her patient looked put together as usual, she could see the exhaustion in her eyes. “You don’t look like yourself,” the therapist agreed. The patient had…
Given the disproportionate impact that COVID-19 has on older adults in terms of death and lasting disability, and the impact of common aging-related comorbidities like diabetes and cardiovascular disease, Buck Institute professor and practicing geriatrician John Newman, MD, PhD, can make a compelling argument that those infected with the SARS-CoV2 virus are suffering from an…
In a clinical trial evaluating a novel immunotherapy option for cancer treatment, a child with rhabdomyosarcoma, a form of muscle cancer, that had spread to the bone marrow, showed no detectable cancer following treatment with chimeric antigen receptor (CAR) T cells that were engineered to target the HER2 protein on the surface of the cancer…
By now, we’re all aware that COVID-19 is especially dangerous for older adults–the older you are, the higher your risk for serious illness and even death if you contract the virus. Because there is no treatment or a vaccine yet, it’s vitally important that we practice social distancing and wear masks to protect ourselves from…
July 15, 2020 – Since the start of the COVID-19 pandemic, thousands of Americans have had to delay recommended but elective orthopedic surgical procedures, such as joint replacement surgery or knee arthroscopy. Now an expert panel has issued recommendations to guide safe resumption of elective orthopedic surgery. The guidelines appear in the July 15, 2020…
NEW YORK, NY (July 15, 2020) – A study supported by the Alzheimer’s Drug Discovery Foundation and published today in JAMA Network Open provides the first evidence that rotigotine, a drug that acts on dopamine transmission in the brain, improves cognitive function in patients with mild-to-moderate Alzheimer’s disease. While rotigotine did not show a significant…
Boston, MA — More than 3 million people in the United States have been infected with COVID-19 and more than 130,000 have died. More people have died of COVID-19 in the U.S. than in any other country, but few studies offer national data on the factors that may contribute to outcomes for critically ill patients.…
Door knobs, light switches, shopping carts. Fear runs rampant nowadays when it comes to touching common surfaces because of the rapid spread of the coronavirus. A Virginia Tech professor has found a solution. Since mid-March, William Ducker, a chemical engineering professor, has developed a surface coating that when painted on common objects, inactivates SARS-CoV-2, the…
Washington, DC – July 15, 2020 – Metabolic syndrome increases the risk of severe disease from viral infection, according to a review of the literature performed by a team of researchers from St. Jude Graduate School of Biomedical Sciences and the University of Tennessee Health Science Center, both in Memphis. The research appears this week…
An analysis of immune responses in 42 COVID-19 patients, both infected and recovered, identified immune signatures that distinguish severe COVID-19 cases. Notably, the analysis features insights not only into adaptive immune cell responses, but also those of innate immune cells responding to the virus. The findings will inform development of COVID-19 therapeutics. As the global…